Maine Updates Licensure Requirements for Prescription Drug Manufacturers and Wholesalers

The State of Maine has enacted legislation modifying the licensure requirements for prescription drug manufacturers and wholesalers under the Maine Pharmacy Act.

The change allows companies to apply for a Maine license before obtaining certain federal registration numbers, which were previously required at the time of application.

The legislation was passed as an emergency measure, meaning it took effect immediately upon approval. The effective date is 03/03/2026.

Federal Registration Numbers No Longer Required at Time of Application

Under prior Maine law, prescription drug manufacturers and wholesalers were required to submit their federal registration information as part of the initial state licensing application. This included registration numbers issued by:

• The U.S. Drug Enforcement Administration (DEA)
• The U.S. Food and Drug Administration (FDA)

With the new legislation, applicants may now apply for licensure even if these federal registration numbers have not yet been obtained.

This change is intended to remove delays in the licensing process for companies seeking authorization to operate in the state.

Federal Registration Must Be Submitted Once Obtained

Although federal registration numbers are no longer required at the time of application, companies must still submit them to the Maine Board of Pharmacy once they are issued.

Specifically, the updated law requires that:

• Applicants provide their DEA or FDA registration numbers, if available, when completing the license application form.
• If those numbers have not yet been obtained, the applicant must file the registration numbers with the Maine Board of Pharmacy once they are     issued.

The license application form must also include the applicant’s name, address, contact information, ownership status, and whether the entity operates as a manufacturer or wholesaler.

Failure to Submit Federal Registration May Trigger Enforcement

The legislation also gives the Maine Board of Pharmacy the authority to take action if required federal registration information is not submitted after it becomes available.

The Board may:

• Deny a license
• Refuse to renew a license
• Impose disciplinary sanctions

These actions may occur if a manufacturer or wholesaler fails to file the applicable federal registration numbers with the Board once they are obtained.

Why This Matters

For pharmaceutical manufacturers and wholesale drug distributors, the change may simplify the initial licensing process in Maine by allowing companies to move forward with state licensure while federal registrations are still pending.

However, companies should ensure they have internal processes in place to promptly submit federal registration numbers to the Maine Board of Pharmacy once they are issued. Failure to do so could impact license status or renewal eligibility.

Organizations operating across multiple states should also monitor regulatory updates like this to ensure their state licensing documentation and reporting requirements remain up to date.

LighthouseAI Regulatory Monitoring

Stay up to date with all regulatory updates across the country.

LighthouseAI state licensing software offers automated surveillance capabilities that will send you notifications like these for all US states and jurisdictions.

Not only that, but they are tailored to your specific business activities and product portfolio. No more weeding through each and every regulation.

Only receive the notifications that are pertinent to you. Saving you hours of research time.

Contact us to learn more: Contact LighthouseAI

Join the LighthouseAI Mailing List

Receive additional news, trends, and insights about the US pharmaceutical supply chain from LighthouseAI.

‍Join the Mailing List